← 返回

肺腺癌中 TIL(肿瘤浸润淋巴细胞)的工程化特征评估

英文原题:Feature Engineering Assessment of Tumor Infiltrating Lymphocytes in Lung Adenocarcinoma.

查看英文原题

Feature Engineering Assessment of Tumor Infiltrating Lymphocytes in Lung Adenocarcinoma.

PubMed 2024/07/01(内容时间) Annu Int Conf IEEE Eng Med Biol Soc

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

TIL(肿瘤浸润淋巴细胞)正逐渐成为免疫治疗的预后标志物。目前,TIL由病理学家在肿瘤组织的苏木精-伊红(H&E)染色切片上进行评估。这种方法耗时,且存在观察者间变异。本研究旨在提出一种基于机器学习的算法,称为特征工程TIL评估(FTA),利用腺癌元数据(即病史、临床和病理数据)进行TIL的自动评估。该算法为弹性网络,通过贝叶斯优化进行调优,并通过留一受试者交叉验证进行验证。获得的系数用于特征排序。结果证实了FTA的良好性能,总体平均绝对误差为2.1%,一致性相关系数为0.71,Bland-Altman图中的差异为-0.001。获得的特征排序揭示了性别的关键作用,这与临床文献一致。总之,FTA是首个不依赖图像的自动TIL评估方法,有潜力解决观察者间变异和经典方法耗时的问题。

展开英文摘要原文

Tumor-Infiltrating Lymphocytes (TIL) are emerging as immunotherapy prognostic markers. Currently, TIL are assessed on hematoxylin and eosin (H&E)-stained slides of tumor tissue by pathologists. This approach is time-consuming, and subjected to inter-observer variability. The aim of this study is to propose a machine learning-based algorithm, called Feature Engineering TIL Assessment (FTA), for the automatic TIL assessment by using adenocarcinoma metadata (i. e. , anamnestic, clinical and pathological data).

The algorithm is an Elastic Net, tuned by Bayesian Optimization and validated by Leave-One-Subject-Out cross validation. Obtained coefficients were used for feature ranking. Results confirms the goodness of performance of FTA, with an overall Mean Absolute Error of 2. 1%, Concordance Correlation Coefficient equal to 0. 71 and difference in the Bland- Altman plot equal to -0. 001. The obtained feature ranking revealed the key role of gender, as confirmed by the clinical literature.

In conclusion, FTA is the first image-independent automatic TIL assessment procedure, having the potential to address challenges associated with inter-observer variability and the time-consuming nature of classical procedures.

论文信息

作者
Bruschi G、Sbrollini A、Pecci F、Cognigni V、Paoloni F、Galassi T、Cantini L、Morettini M
期刊
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2024 Jul
原文标识
PubMed 40039199 · DOI 10.1109/EMBC53108.2024.10782758